cu-20401
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 20, 2021 (NCT05173883)
Timeline
Indications
Mechanism of action
- CollagenINHIBITOR
Collagen inhibitor
- Collagen alpha-2(I) chain (COL1A2) ↗
- Collagen alpha-1(I) chain (COL1A1) ↗
- Collagen alpha-1(II) chain (COL2A1) ↗
- Collagen alpha-1(III) chain (COL3A1) ↗
- Collagen alpha-1(IV) chain (COL4A1) ↗
- Collagen alpha-1(V) chain (COL5A1) ↗
- Collagen alpha-1(VI) chain (COL6A1) ↗
- Collagen alpha-1(XI) chain (COL11A1) ↗
- Collagen alpha-1(XV) chain (COL15A1) ↗
- Collagen alpha-1(XVIII) chain (COL18A1) ↗
- Collagen alpha-1(XXIV) chain (COL24A1) ↗
- Collagen alpha-1(XXVII) chain (COL27A1) ↗
- Collagen alpha-1(XXVIII) chain (COL28A1) ↗
- Collagen alpha-2(IV) chain (COL4A2) ↗
- Collagen alpha-2(V) chain (COL5A2) ↗
- Collagen alpha-2(VI) chain (COL6A2) ↗
- Collagen alpha-2(XI) chain (COL11A2) ↗
- Collagen alpha-3(IV) chain (COL4A3) ↗
- Collagen alpha-3(V) chain (COL5A3) ↗
- Collagen alpha-3(VI) chain (COL6A3) ↗
- Collagen alpha-4(IV) chain (COL4A4) ↗
- Collagen alpha-5(IV) chain (COL4A5) ↗
- Collagen alpha-5(VI) chain (COL6A5) ↗
- Collagen alpha-6(IV) chain (COL4A6) ↗
- Collagen alpha-6(VI) chain (COL6A6) ↗
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06194188 | Phase 2 | Dec 20, 2023 | Government of China, Union Therapeutics |
| NCT05195541 | Phase 1/Phase 2 (Phase 2) | Feb 27, 2022 | Government of China |
| NCT05173883 | Phase 1 | Dec 20, 2021 | Government of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 3 | 2 | 2021 |
| Union Therapeutics | For profit | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1